Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients-Reference-Cited by-同舟云学术

Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients

Published:2014-07-15 Issue:24 Volume:23 Page:6458-6469
ISSN:1460-2083
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Hathout Yetrib,Marathi Ramya L.,Rayavarapu Sree,Zhang Aiping,Brown Kristy J.,Seol Haeri,Gordish-Dressman Heather,Cirak Sebahattin,Bello Luca,Nagaraju Kanneboyina,Partridge Terry,Hoffman Eric P.,Takeda Shin'ichi,Mah Jean K.,Henricson Erik,McDonald Craig

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/23/24/6458/13907404/ddu366.pdf

Reference65 articles.

1. Duchenne muscular dystrophy. A population study;Danieli;Hum. Genet.,1977

2. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management;Bushby;Lancet Neurol.,2009

3. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group;Griggs;Arch. Neurol.,1991

4. Update on the management of Duchenne muscular dystrophy;Manzur;Arch. Dis. Child.,2008

5. Glucocorticoid corticosteroids for Duchenne muscular dystrophy;Manzur;Cochrane Database Syst. Rev.,2008

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I/II Trial of Brogidirsen: Dual-Targeting Antisense Oligonucleotides for Exon 44 Skipping in Duchenne Muscular Dystrophy;2024-08-30

2. Protein biomarker signature in patients with spinal and bulbar muscular atrophy;JCI Insight;2024-05-30

3. NLRP3 Contributes to Sarcopenia Associated to Dependency Recapitulating Inflammatory-Associated Muscle Degeneration;International Journal of Molecular Sciences;2024-01-24

4. N-terminal titin fragment: a non-invasive, pharmacodynamic biomarker for microdystrophin efficacy;Skeletal Muscle;2024-01-16

5. How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?;Proteomes;2024-01-16